Expert Consensus on the Methodology for Assessing Recurrence Risk of Cervical Cancer (2025 Edition)
Abstract：1. Background
Cervical cancer is the most common malignant tumor of the female reproductive system, with incidence and mortality ranking fourth among all female malignancies [1]. The 5-year survival rate for early-stage cervical cancer patients who receive standard treatment can reach as high as 90%, but some patients still experience recurrence and metastasis after surgery [2-3]. Surveys have found that the overall recurrence rate of cervical cancer surgical cases in some regions of China from 2004 to 2019 was 12.5%, and older age at initial diagnosis and higher tumor stage were associated with a higher recurrence rate [4].
Keywords：cervical cancerrecurrence riskevaluation methodologyexpert consensus
Publication Date：2025-08-02
Online Publishing Date：2025-09-30(First online date of this platform, not the publication date of the document)
Pages：8( 822-829 )